Live Pharmaceutical Import data of Russia imports from china under HS Code 294130 via Port Vladivostok-customs-post , our Russia customs import data reports include date, value, quantity, product description, HS code, port, country, and Russia pharmaceutical importers data
Date |
HS Code |
Product Description |
Origin Country |
Customs |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-16 00:00:00 |
2941300009
|
DOXYCYCLINE HYCLATE IS A PHARMACEUTICAL SUBSTANCE IN THE FORM OF A YELLOW CRYSTALLINE POWDER FOR THE PRODUCTION OF MEDICINES FOR VETERINARY USE: | CHINA | VLADIVOSTOK CUSTOMS POST | 650 | KG | 197275 | Importer Name |
2024-04-16 00:00:00
DOXYCYCLINE HYCLATE IS A PHARMACEUTICAL SUBSTANCE IN THE FORM OF A YELLOW CRYSTALLINE POWDER FOR THE PRODUCTION OF MEDICINES FOR VETERINARY USE:
650
KG
197275
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 294130 for Russia pharmaceutical imports from Thailand via Port Vladivostok-customs-post.
Port Vladivostok-customs-post typically refers to a port that is used for handling and forwarding shipments into Russia, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Russia pharmaceutical imports from china under HS code 294130 via Port Vladivostok-customs-post.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
